Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…ical. A man in his 60s with glioblastoma multiforme on adjuvant temozolomide and cranial radiation presented with a 10-day history of progre…
…ing for sustained remission or low disease activity (LDA), with prednisone (PDN) <=5 mg/day and withdrawal when possible. However, real-wo…
…I was 0 (0-1.25). Standard treatments during pregnancy included prednisone (83%), antimalarials (86%), azathioprine (47%); calcineurin-inh…
…ents with persistent disease activity despite standard therapy. Anifrolumab, a monoclonal antibody targeting the type I interferon receptor…
… points; 95% confidence interval [CI], 12.5 to 33.6; P<0.0001). Obinutuzumab was superior to placebo with statistically significant benefit …
…et classification criteria for SLE or other SARDs. All received prednisone <10 mg/day and no immunosuppressants. Soluble SIGLEC1 was measu…
…1 (56.6%), preserved FEV1/FVC ratio. Treatment with enoxaparin, furosemide, sildenafil, ivabradine and bosentan was initiated.After 3 mont…
…ade the patient sleep on the left hip. He had a therapy of 5 mg prednisone, vitamins B12 and D, a proton-pump inhibitor, and topical eye d…
…rienced an improvement 74.6% had managed to completely withdraw prednisone .77.6% were still on BEL treatment.Conclusions In the Spanish c…
…, ANI was administered concomitantly with antimalarials (n=16), mycophenolate mofetil (n=11), tacrolimus (n=4), azathioprine (n=2), methotrexate (n=1…
…A 1:1280, anti-dsDNA positive, low C3/C4). Initial therapy with hydroxychloroquine (200 mg/day) and low-dose prednisone (7.5 mg/day) achieved clin…
…ive analysis of 210 SLE patients treated between 2000-2022 with rituximab. Super-responders were defined by: (1) at least 3 years of foll…